Cibc World Market Inc. Medpace Holdings, Inc. Transaction History

Cibc World Market Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$372.0 - $424.34 $80,352 - $91,657	216 Added 7.15%	3,238 $1.33 Million
Q1 2024 May 13, 2024	SELL	$284.87 - $413.31 $67,799 - $98,367	-238 Reduced 7.3%	3,022 $1.22 Million
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $119,448 - $164,157	525 Added 19.2%	3,260 $999,000
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $414,144 - $498,555	1,770 Added 183.42%	2,735 $662,000
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $180,705 - $231,764	965 New	965 $232,000
Q4 2022 Feb 13, 2023	BUY	$153.06 - $226.57 $339,180 - $502,079	2,216 New	2,216 $471,000
Q4 2018 Feb 13, 2019	SELL	$46.97 - $63.98 $396,473 - $540,055	-8,441 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$43.25 - $63.74 $365,073 - $538,029	8,441 New	8,441 $506,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.